Tesamorelin alone reduces visceral fat by 15 to 20% without necessarily changing scale weight
For reference, Wegovy and Zepbound are currently FDA-approved for obesity, while Ozempic and Mounjaro are approved for type 2 diabetes
According to the FDA submission for Wegovy approval (the weight loss medication produced by NovoNordisk that contains the active ingredient semaglutide), the average weight loss over 1 year and 4 months was 15.1%
There were 468 reports of GLP-1-related thyroid cancer cases to the Food and Drug Administration between 2006 and 2023, including 18 deaths
Most cases of dehydration respond well to rest, fluids, and time but some dont, and the difference matters
His leadership is rooted in innovation, compassion, and accountability - always making sure patients feel supported and cared for on their wellness journey